Somerset, NJ – Nov. 6, 2015 – LabVantage Solutions and Cambridge Biomedical announce the implementation of LabVantage laboratory information management system (LIMS).
After an extensive investigation of LIMS systems suitable for both clinical diagnostic and clinical research aspects of their business, Cambridge Biomedical has entered into an agreement to implement LabVantage with a targeted launch in spring 2016.
“This marks a milestone on our continuing commitment to providing our clients best-in-class service and our continual commitment to quality” said Anthony Davis, Director of Quality Assurance “I am proud to be the project leader on this endeavor and excited by the tremendous opportunities this will bring to our organization.”
Peter Bailey, LabVantage CEO stated, “We are excited to begin our partnership with Cambridge Biomedical, a world class leader in bioanalytical services. Our goal at LabVantage is to help companies such as Cambridge Biomedical use technology to run their laboratories more efficiently. We know our LIMS solution will enable Cambridge Biomedical to continue their advances in scientific research.”
LabVantage, a configurable, web-based LIMS, is trusted by industry leaders worldwide to run their laboratories and operate with the highest level of efficiency, effectiveness and quality. Whether it’s in the preclinical, clinical, and post market stages of drug or device development LabVantage’s solutions offer a level of security organizations such as Cambridge Biomedical need to better support their clients.
About LabVantage Solutions
LabVantage Solutions, Inc., the leading global laboratory informatics provider, is headquartered in Somerset, NJ and has offices around the world. Their industry-leading solutions and world-class services are the result of 30+ years of experience in laboratory informatics. LabVantage offers a comprehensive portfolio of products and services that enable companies to innovate faster in the R&D cycle, run labs more efficiently, improve manufactured product quality, achieve accurate recordkeeping and comply with regulatory requirements. LabVantage serves thousands of labs across the globe from industries such as pharmaceutical, biotech, food & beverage, chemicals, oil and gas, consumer packaged goods and more.
LabVantage is a highly configurable, Web-based LIMS that powers thousands of laboratories globally, large and small. Built on a platform that is widely recognized as the best in the industry, LabVantage can support thousands of users as well as interface with instruments and other enterprise systems. It is the best choice for industries ranging from pharmaceuticals and consumer goods to molecular diagnostics and biobanking. LabVantage domain experts advise customers on best practices and maximize their ROIs by optimizing LIMS implementation with a rapid and successful deployment. To find out more, visit https://www.labvantage.com/.
About Cambridge Biomedical
Cambridge Biomedical, based in Boston, Massachusetts, supports sponsors by developing customized assays for small and large molecules, biomarkers, and other critical analytes, along with validation and sample testing in our CLIA certified and CAP accredited, GLP/GCLP compliant facilities, The Company has extensive expertise in technology transfer, assay development, optimization and validation. It also offers specific services in analytical support for PK/PD studies, biomarker development, clinical assay development, assay validation, specimen analysis, and testing services in support of clinical trial and drug or device development. Our personalized project methodology, along with a focus on delivering quality results and regulatory submission ready documentation and rapid turnaround times, ensures we meet our client’s product development timelines.
